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Drug screeningWe have studied mitochondrial Ca2+ transport and the permeability transition (PT) in the teleost zebraﬁsh
(Danio rerio), a key model system for human diseases. Permeabilized zebraﬁsh embryo cells displayed a
mitochondrial energy-dependent Ca2+ uptake system that, like the Ca2+ uniporter of mammals, was
inhibited by ruthenium red. Zebraﬁsh mitochondria underwent a Ca2+-dependent PT that displayed Pi-
dependent desensitization by cyclosporin A, and responded appropriately to key modulators of the
mammalian PT pore (voltage, pH, ubiquinone 0, dithiol oxidants and cross linkers, ligands of the adenine
nucleotide translocator, arachidonic acid). Opening of the pore was documented in intact cells, where it led
to death that could largely be prevented by cyclosporin A. Our results represent a necessary step toward the
use of zebraﬁsh for the screening and validation of PTP inhibitors of potential use in human diseases, as
recently shown for collagen VI muscular dystrophy [Telfer et al., 2010].capacity; Cs, Cyclosporin; CyP,
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The Permeability Transition (PT) [1] is increasingly recognized as
an effector mechanism of cell death [2,3]. The PT is an inner
membrane permeability increase to solutes with molecular mass up
to about 1500 Da, which leads to membrane depolarization, dereg-
ulation of ion homeostasis, depletion of pyridine nucleotides and ATP
hydrolysis; PT-dependent cristae junction remodeling and matrix
swelling favor cytochrome c release [4], which is maximal if outer
membrane rupture takes place [5]. The PT is highly regulated, and it is
presumed to occur through opening of a protein channel, the PT pore
(PTP). In spite of major efforts the molecular nature of the PTP
remains unknown [2,3]. The only protein involved in the PT identiﬁed
so far is cyclophilin (CyP) D [6–8], the matrix receptor for cyclosporin
(Cs) A [9–12]. We think that CyPD sensitizes the PTP to the inducing
effects of Ca2+ and of other agonists by shielding an inhibitory site for
Pi; genetic ablation of CyPD or its inhibition by CsA allows PTP
desensitization by Pi, an effect that is lost when Pi is replaced by other
anions like its analogs arsenate (Asi) and vanadate, or by bicarbonate
(see ref. [13] and discussion therein). Mice with genetic inactivationof CyPD have been used to address the role of the PTP in disease, but
conclusions based on this genotype must be taken with great caution
because a PT still occurs in CyPD-null mitochondria, or in CyPD-
competent mitochondria treated with CsA [14–17]. Indeed, and as we
have noted before [15], CyPD-null animals can only address the role of
CyPD, not of the PTP, in pathophysiology; and it is hard to make
predictions on whether conditions allowing CyPD-dependent modu-
lation of the PTP (speciﬁcally, an adequate concentration of Pi) will
occur in speciﬁc disease paradigms.
The above considerations highlight the need for the development
(i) of selective inhibitors of the PTPactingat sites different fromCyPDand
(ii) of model disease systems for the PTP that could be amenable to the
rapid testing of drugs identiﬁed by high-throughput screening. We have
provided the proof of principle that CyPD-independent sites exist with
the discovery of the PTP inhibitory properties of quinones and of Ro 68-
3400, which indeed displayed additive effects with those of CsA [18–22].
The vertebrate teleost zebraﬁsh (Danio rerio) has recently become
an attractive tool to uncover the complicated pathways regulating the
biological processes that underlie several human diseases [23]. The
importance of this model to PTP studies is dramatically highlighted by
the recent ﬁndings that Ullrich Congenital Muscular Dystrophy
(UCMD) can be modeled in zebraﬁsh [24]; and that, like the mouse
model [25–27], it can be cured with CsA through PTP inhibition [24].
Here, we have carried out a thorough characterization of mitochon-
drial Ca2+ transport and the PT in zebraﬁsh. We show that zebraﬁsh
mitochondria readily undergo a Ca2+-dependent PT that displays a Pi-
dependent desensitization by CsA, and that responds appropriately to
key modulators of the mammalian PTP.
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2.1. Animals
Adult zebraﬁsh were maintained in the facility of University of
Padova containing aerated, 28.5 °C-conditioned saline water accord-
ing to standard protocols. Fishwere kept under a 14-h light–10-h dark
cycle. For mating, males and females were separated in the late
afternoon and the next morning were freed to start courtship, which
ended with eggs deposition and fecundation. Eggs were collected,
washed with ﬁsh water (0.5 mM NaH2PO4, 0.5 mM NaHPO4, 0.2 mg/l
methylene blue, 3 mg/l instant ocean), and maintained at 28.5 °C in
ﬁsh water supplemented with an antibiotic-antimycotic cocktail
(50 μg/ml ampicillin, 100 units/ml penicillin and 0.1 mg/ml strepto-
mycin, Biochrom, 3.3 μg/ml amphotericin B, Bristol-Myers-Squibb).
2.2. Isolation of cells from zebraﬁsh embryos
Zebraﬁsh cells were prepared from 6-h-old embryos (gastrula
stage). To minimize bacterial contamination the antibiotic-antimycotic
cocktail was included in all solutions used. Embryos were treated with
0.1% sodium hypochlorite in Holtfreter's solution (15 mM NaCl,
0.17 mMKCl, 0.23 mMCaCl2, and 0.6 mMNaHCO3, pH 7.6), abundantly
washed with Holtfreter's solution, dechorionated and dissociated in
0.25% trypsin/EDTA by pipetting for 2 min. Chorions and undissociated
embryoswere separated from the cell suspensionwith aﬁlter,while the
embryonic cell suspensionwas dilutedwith serum-containingmedium
and centrifuged at 800g for 3 min. Cells were used immediately or
plated in zebraﬁsh growthmedium (Leibovitz-15medium L-15, Gibco),
supplemented with 3% fetal bovine serum, 2 mM L-glutamine, 100
units/ml penicillin, 0.1 mg/ml streptomycin, 3.3 μg/ml amphotericin B
on poly-D-lysine-coated supports (UV-sterilized 24-mm diameter glass
coverslips, plastic ﬂasks or wells).
2.3. Measurements on permeabilized cells
Freshly dissociated cells from embryos were washed in 130 mM
KCl, 10 mM Tris-MOPS, 1 mM Pi-Tris, pH 7.4 and then incubated with
100 μM digitonin in the same buffer supplemented with 1 mM EGTA-
Tris for 10 min. Digitonin was then washed away by spinning cells at
800g in 130 mM KCl, 10 mM Tris-MOPS. Measurements of membrane
potential, extramitochondrial Ca2+, and PN oxidation-reduction
status were carried out ﬂuorimetrically with Fluoroskan Ascent FL
(Thermo Electron Corporation) on permeabilized cell suspension at
25 °C in the presence of 5 mMglutamate-Tris and 2.5 mMmalate-Tris.
Experiments were performed in 96-well black plates in a volume of
100 μl per well. Unless otherwise speciﬁed, the incubation buffer was
130 mM KCl, 10 mM Tris-MOPS, 1 mM Pi-Tris, 10 μM EGTA-Tris,
pH 7.4. Membrane potential was followed based of the ﬂuorescence
changes of 0.5 μM rhodamine 123 (Molecular Probes) with the ﬁlter
couple λexc 485 nm, λem 525 nm. In parallel, the PN oxidation-
reduction status was evaluated based on endogenous NAD(P)H
ﬂuorescence (ﬁlter couple: 355–460 nm). Extramitochondrial Ca2+
concentration was measured in the presence of 0.5 μM Ca2+-Green
5 N (Molecular Probes) with the ﬁlter couple λexc 485 nm, λem
525 nm.
2.4. Measurements of mitochondrial membrane potential in intact cells
Cellular ﬂuorescence images were acquired at room temperature
with an Olympus IX71/IX51 inverted microscope equipped with a
digital camera. Adherent cells were ﬁrst washed with phosphate-
buffered saline and then incubated for 30 min at room temperature in
serum-free L-15 medium supplemented with 4 μMCsH (which inhibits
the plasmamembranemulti-drug resistance P-glycoprotein, but not the
PTP) and, when speciﬁed, 1.6 μM CsA or 0.6 μM FK506. Mitochondrialmembrane potential was followed based on the accumulation of 10 nM
tetramethylrhodamine methyl ester (TMRM, Molecular Probes) as
previously described. For detection of TMRM ﬂuorescence, 568±25 nm
bandpass excitation and 585 nm longpass emission ﬁlter settings were
used. Sequential digital TMRM ﬂuorescence images were collected
every 3 min with exposure time of 100 ms (41.68% illumination
intensity). Additions were performed between two acquisitions in the
above medium and added volume never exceeded 1% of the incubation
volume. At the end of each experiment, mitochondria were fully
depolarized by the addition of the protonophore carbonylcyanide-p-
triﬂuoromethoxyphenyl hydrazone (FCCP). Data were acquired and
analyzed using the Cell R Software (Olympus). Clusters of several
mitochondria were identiﬁed as regions of interest and ﬁelds not
containing cells were used as background. Before each experiment, a
light control was performed to ensure that light did not cause
depolarization by itself.
2.5. Cell death assay
Occurrence of cell death was evaluated on the basis of accumu-
lation of Sytox Orange (Molecular Probes). Cells were seeded on 24-
well plates 2 days before the experiment. Adherent cells were washed
with PBS and then incubated for 4 h at room temperature in serum-
free L-15mediumwith the compounds speciﬁed in the ﬁgure legends.
When present, 0.6 μMFK506, 1.6 μMCsA or vehicle (DMSO)were pre-
incubated for 30 min before further treatments. Cells were then
incubated for 30 min with 0.2 μM Sytox Orange and total ﬂuorescence
intensities were acquired with the Fluoroskan Ascent FL apparatus.
Fluorescence from wells containing medium plus Sytox Orange was
considered as background. Digitonin was used as the fully permea-
bilizing agent, and Sytox ﬂuorescence in digitonin-treated cells was
taken as 100%.
2.6. Chemicals
All chemicals were of the highest purity commercially available,
and unless stated otherwise they were from Sigma. Stock solutions
were prepared according to the manufacturer's instructions.
3. Results
Preparation of mitochondria from zebraﬁsh gave a low yield of
organelles of poor quality. We therefore used digitonin-permeabilized
cells from 6-h-old embryos (gastrula stage), an approach that allows
measurements to be made with minimal disruption of mitochondrial
integrity [28]. A 20 μM Ca2+ pulse was readily taken up by this
preparation, but uptake was followed by spontaneous release of the
accumulated cation (Fig. 1A, trace a). Treatmentwith CsA prevented Ca2+
release (Fig. 1A, trace b), indicating that it was due to PTP opening. Ca2+
uptake was prevented by pretreatment with ruthenium red, the classical
inhibitor of the mitochondrial Ca2+ uniporter [29] (Fig. 1A, trace c). No
further Ca2+ release could be seen upon inhibition of respiration with
rotenone (Fig 1A). When Pi was replaced by Asi, onset of Ca2+ release
occurredearlier, consistentwitha slightlymorepronouncedPTP-inducing
effect of Asi compared to Pi [13]. Note that the initial rate of Ca2+ uptake
was the same in Pi- andAsi-containingmedia (compare traces a in panels
A and B). This ﬁnding indicated that, like in liver mitochondria [13],
maintenance and regeneration of the membrane potential was not
affected byAsi. As expected [13], CsAwas not able to prevent Ca2+ release
in the Asi-containing medium while Ca2+ uptake was still inhibited by
ruthenium red (Fig 1B).
Consistent with onset of a Ca2+-dependent PT (i) addition of Ca2+
caused a profoundmitochondrial depolarization (Fig. 2A, trace a)which
was prevented by the addition of CsA, a condition under which only the
expected, transient depolarization linked to Ca2+ uptake was observed
(Fig. 2A, trace b); and (ii) the pyridine nucleotide pool underwent full
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Fig. 1. Ca2+ transport in permeabilized zebraﬁsh cells. Freshly dissociated cells were
permeabilized with 100 μM digitonin as speciﬁed in Materials and methods, and
incubated in 130 mM KCl, 10 mM Tris-MOPS, 10 μM EGTA-Tris, 5 mM glutamate-Tris,
2.5 mM malate-Tris, pH 7.4, 0.5 μM Ca2+-Green 5 N and 1 mM Pi-Tris (panel A) or
1 mM Asi-Tris (panel B). Extramitochondrial Ca2+ was monitored in the absence of
further additions (traces a) or in the presence of 1.6 μM CsA (traces b), or of 10 μM
ruthenium red (traces c). Where indicated (arrows) 20 μM Ca2+, 0.5 μM FCCP and 2 μM
rotenone (Rot) were added. Fluorescence is expressed in Arbitrary Units. Experiments
were performed in triplicate and error bars report the standard deviation.
Fig. 3. Effects of various inhibitors and inducers of the permeability transition on the
mitochondrial calciumretention capacityofpermeabilizedzebraﬁshcells. Freshlydissociated
cells were permeabilized with digitonin and incubated in 130 mM KCl, 10 mM Tris-MOPS,
10 μMEGTA-Tris, 1 mMPi-Tris, 5 mMglutamate-Tris, 2.5 mMmalate-Tris, and 0.5 μMCa2+-
Green 5 N. The calcium retention capacity wasmeasured in the absence of further additions
(basal, CRC0) or in the presence of 1%( v/v) DMSO, 5 μM oligomycin (Oligo), 1 mM DTT,
0.6 μM FK506, 1.6 μM CsA, 10 μM Ub0 plus 1 mM DTT added 2 min after Ub0, 100 μM ADP
plus 5 μMoligomycin, 20 μMbonkgrekate, 25 μM atractylate, 50 μM arachidonate, or 50 μM
diamide. Thewhite bars in the right panel report the effects of 1.6 μMCsA. Experimentswere
performed in triplicate and are reported as the mean±standard deviation.
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that is observed during the process of Ca2+ uptake when the PT is
prevented byCsA (Fig. 2B, traceb). Of note, the addition of rotenonewas
not followed by reduction of pyridine nucleotides irrespective of the
presence of CsA, indicating that FCCP caused PTP opening and loss of
matrix pyridine nucleotides (see e.g. [30]).
The sensitivity of zebraﬁsh mitochondria to a panel of PTP
inhibitors and inducers was investigated next. The CRC was increased
by CsA, ADP, bongkrekate and Ub0, the effects of CsA and Ub0 being
additive (Fig. 3, left panel); while it was decreased by acidiﬁcation
(results not shown), atractylate, arachidonate and diamide in a
process that maintained at least partial sensitivity to CsA (Fig. 3, right
panel). In order to test the voltage-dependence of the PTP,
mitochondria were pulsed with a load of Ca2+ that was not large
enough to trigger the PT, followed by the addition of ruthenium red
(to prevent Ca2+ release on the uniporter) and then FCCP, which
caused a concentration-dependent Ca2+ efﬂux (Fig. 4, panel A). As in
mammalian mitochondria [31], FCCP-induced Ca2+ release under
these conditions is due to PTP opening and could indeed be inhibited
by CsA (Fig. 4, panel A'). In similar protocols we found an exquisite
sensitivity of PTP opening to the dithiol cross-linker PhAsO [32,33]
(Fig. 4, panels B, B') and to clotrimazole, which displaces hexokinase
from the outer membrane [28,34–36] (Fig. 4, panels C, C').Ca2+ FCCP
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Fig. 2. Effect of Ca2+ and uncoupler onmembrane potential and oxidation-reduction status
of pyridine nucleotides in permeabilized zebraﬁsh cells. Freshly dissociated cells were
permeabilized with digitonin as speciﬁed in Materials and methods, and incubated in
130 mM KCl, 10 mM Tris-MOPS, 1 mM Pi-Tris, 10 μMEGTA-Tris, 5 mM glutamate-Tris, and
2.5 mM malate-Tris, pH 7.4. Panel A, mitochondrial membrane potential was monitored
withRhodamine123 in the absenceof furtheradditions (tracea)or inthepresenceof1.6 μM
CsA (trace b); where indicated (arrows) 20 μMCa2+, 0.5 μMFCCP and 2 μM rotenone (Rot)
were added. Panel B, status of endogenous pyridine nucleotides was monitored; additions
were as in panel A. In all panels ﬂuorescence is expressed in Arbitrary Units. Experiments
were performed in triplicate and error bars report the standard deviation.We ﬁnally asked the question of whether PTP opening can be
measured in intact zebraﬁsh cells, and whether it affects cell survival.
We monitored mitochondrial membrane potential in situ with the
sensitive TMRM accumulation method [37], and its response to the
addition of 10 μM clotrimazole, i.e. a concentration that is lower than
that causing mitochondrial toxicity [28]. Addition of clotrimazole was
followed by mitochondrial depolarization (Fig. 5, panel A) and by
onset of cell death (Fig. 5, panel B) which could both be largely
prevented by CsA but not FK506 (Fig. 5).
4. Discussion
The speciﬁc importance of zebraﬁsh as a model system for PTP-
dependent diseases became apparent only very recently. Through
injection of morpholino to zebraﬁsh exon 9 of col6a1 Dowling andFCCP (nM)Ca2+
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Fig. 4. Effects of ruthenium red plus FCCP, phenylarsine oxide and clotrimazole on
mitochondrial calcium retention by permeabilized zebraﬁsh cells. Freshly dissociated cells
were permeabilized with digitonin and incubated in 250 mM sucrose, 10 mM Tris-MOPS,
5 mM glutamate-Tris, 2.5 mM malate-Tris, 1 mM Pi-Tris and 0.5 μM Ca2+-Green 5 N.
Where indicated 20 μMCa2+ and 10 μM ruthenium red (RR) were added, followed by the
indicated concentrations of FCCP, phenylarsine oxide (PhAsO) and clotrimazole (Clotr). In
panels A'–C' the incubationmediumwas supplementedwith 1.6 μMCsA. The additions of
RR, FCCP, PhAsO and Clotrimazole were performed manually, and breaks in the traces
denote the ≈20-s intervals required for each addition and subsequent shaking of the
plates. The experiments reported are representative of three per condition.
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Fig. 5. Effect of clotrimazoleonmembranepotential andviability of zebraﬁsh cells. Zebraﬁsh
cells obtained fromdissociation of 6-h embryoswere studied 2 days after plating, incubated
in the presence of 10 nM TMRM, and their images collected with the Olympus IX71/IX51
invertedmicroscope using a 40× oil immersion objective. Panel A, changes ofmitochondrial
TMRM ﬂuorescence (expressed as the % of initial ﬂuorescence) were followed over time;
where indicated 10 μM clotrimazole (Clotr) and 4 μM FCCP were added in the absence of
further treatments (closed squares) or in the presence of 0.6 μMFK506 (closed triangles) or
of 1.6 μM CsA (open circles) (average of 3 experiments, mean±standard error). Panel B,
cells were incubated with clotrimazole (Clotr) in the presence of vehicle (DMSO 1% v/v,
closed squares), 0.6 μMFK506 (closed triangles) or 1.6 μMCsA(opencircles). After 4 hSytox
Orange was added and cell death assessed as described in Materials and methods. The
results shown were are the mean±standard error of 3 experiments, and values of
ﬂuorescence refer to the % of maximal as obtained in the presence of 100 μM digitonin.
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terminal part of the triple helical domain of collagen VI, which
mimicks the dominant mutations of UCMD [24]. This manipulation
caused an early-onset severe myopathy with motor deﬁcits and
severe ultrastructural changes which, like the mouse model [25–27],
could be cured by CsA through an inhibitory effect on the PTP [24].
The cellular and mitochondrial effects of CsA are not easy to dissect
because of the existence of multiple CyP isoforms and because of the
inhibitory effects of the CsA⋅CyPA complex on the cytosolic phosphatase
calcineurin [38–40]. As a consequence (i) phospho-NFAT is no longer
dephosphorylatedand thereforeunable to translocate to thenucleus and
to trigger the IL-2-dependent activation of the immune response against
the transplant [38–40]; and (ii) calcineurin-dependent dephosphoryla-
tion at Ser637 of the pro-ﬁssion protein Drp1 no longer takes place,
preventing its translocation to mitochondria and inhibiting ﬁssion [41].
The fact that mitochondrial depolarization and cell death induced in
zebraﬁsh embryo cells by clotrimazolewere prevented byCsAbut not by
the calcineurin inhibitor FK506, which acts independently of CyPs,
strongly suggests that calcineurin inhibition is not relevant to cytopro-
tection by CsA, indirectly supporting a mitochondrial PTP-dependent
mechanism. While acute depolarization by clotrimazole was fully
prevented by CsA, inhibition of cell death was only partial (Fig. 5). The
transient nature of the inhibitory effect of CsA on the pore is well known
[42], while the variables involved in the in situ sensitivity to this drug
have begun to be appreciated only recently [13].We therefore think that
even partial sensitivity to CsA represents evidence that the underlying
mechanism involves PTP opening. Although we could not ﬁnd any
speciﬁc studywith FK506 in zebraﬁsh,wenote that its cognate receptors
FKBP have been detected in the common carp (Cyprinus carpio) [43] as
well as in salmon and rainbow trout [44].
Regulated permeability changes can be found across species from
yeast to plants and mammals. Although speciﬁc features may differ, we
have identiﬁed a set of common regulators suggesting that occurrence
of a PT is a highly conserved event [45]. A key point deﬁned inmammals
is regulation by the proton electrochemical gradient; depolarization
favors PTP opening [46] through a putative voltage sensor that can be
tuned by pathophysiological effectors like redox-active and amphiphilic
compounds [47] including fatty acids like arachidonate [48]; while
matrix acidiﬁcation inhibits PTPopening through reversible protonation
of histidyl residues [49].Occurrence of a PT in ﬁsh had so far been demonstrated only in the
great green goby (Zosterisessor ophiocephalus) [50] and in the rainbow
trout (Oncorhynchus mykiss) [51]. In order to assess whether zebraﬁsh
is a good general model for PTP-dependent diseases it was therefore
essential to assess its features in this species. Our present results
demonstrate that zebraﬁsh mitochondria can undergo a Ca2+-
dependent PT that displays Pi-dependent desensitization by CsA,
and that responds in the appropriate manner to the key modulators of
the mammalian PT pore (voltage, pH, Ub0, dithiol oxidants and cross
linkers, ligands of the adenine nucleotide translocator, arachidonic
acid). Of particular interest is the conservation of inhibition by Ub0
because quinones modulate the mammalian PTP through at least 2
separate sites, and their effects are additive with those of CsA,
indicating that they do not act through mitochondrial CyP and thus
providing an additional target for drug screening [18–21].
Zebraﬁsh is an excellent tool for genetic modiﬁcations and large
scale genetic analysis, given its easy manipulation and high
reproductive potential [52]. Moreover, during early developmental
stages its transparency allows to trace single cellular events through
the use of ﬂuorescent microscopy [53]. For the analysis of cellular
dynamics and drugs screening, zebraﬁsh offers a good alternative over
more expensive animal models as many aspects of its cellular biology,
embryonic development and organ formation have been shown to be
regulated by the same genetic mechanisms observed in mammals
[54]. Thus, the present results that the key properties of the PTP of
zebraﬁsh mitochondria are indistinguishable from those of mammals
are an essential step toward the use of zebraﬁsh for the screening and
validation of novel PTP inhibitors of potential use in human diseases.
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